Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Diabetes-attributable mortality in the United States from 2003 to 2016 using a multiple-cause-of-death approach.

Rodriguez F, Blum MR, Falasinnu T, Hastings KG, Hu J, Cullen MR, Palaniappan LP.

Diabetes Res Clin Pract. 2019 Feb;148:169-178. doi: 10.1016/j.diabres.2019.01.015. Epub 2019 Jan 11.

PMID:
30641162
2.

Limitations and Misinterpretations of E-Values for Sensitivity Analyses of Observational Studies.

Ioannidis JPA, Tan YJ, Blum MR.

Ann Intern Med. 2019 Jan 1. doi: 10.7326/M18-2159. [Epub ahead of print]

PMID:
30597486
3.

How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.

Naci H, Salcher-Konrad M, Dias S, Blum MR, Sahoo SA, Nunan D, Ioannidis JPA.

Br J Sports Med. 2018 Dec 18. pii: bjsports-2018-099921. doi: 10.1136/bjsports-2018-099921. [Epub ahead of print] Review.

PMID:
30563873
4.

Cosyntropin testing does not predict response to glucocorticoids in community-acquired pneumonia in a randomized controlled trial.

Blum CA, Schuetz P, Nigro N, Winzeler B, Arici B, Refardt J, Urwyler SA, Rodondi N, Blum MR, Briel M, Mueller B, Christ-Crain M.

Clin Endocrinol (Oxf). 2018 Nov 28. doi: 10.1111/cen.13907. [Epub ahead of print]

PMID:
30485501
5.

Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over.

Du Puy RS, Postmus I, Stott DJ, Blum MR, Poortvliet RKE, Den Elzen WPJ, Peeters RP, van Munster BC, Wolffenbuttel BHR, Westendorp RGJ, Kearney PM, Ford I, Kean S, Messow CM, Watt T, Jukema JW, Dekkers OM, Smit JWA, Rodondi N, Gussekloo J, Mooijaart SP.

BMC Endocr Disord. 2018 Sep 19;18(1):67. doi: 10.1186/s12902-018-0285-8.

6.

Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.

Blum MR, Gencer B, Adam L, Feller M, Collet TH, da Costa BR, Moutzouri E, Dopheide J, Depairon M, Sykiotis GP, Kearney P, Gussekloo J, Westendorp R, Stott DJ, Bauer DC, Rodondi N.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2988-2997. doi: 10.1210/jc.2018-00279.

PMID:
29846630
7.

Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study.

O Riordan D, Aubert CE, Walsh KA, Van Dorland A, Rodondi N, Du Puy RS, Poortvliet RKE, Gussekloo J, Sinnott C, Byrne S, Galvin R, Jukema JW, Mooijaart SP, Baumgartner C, McCarthy V, Walsh EK, Collet TH, Dekkers OM, Blum MR, Kearney PM.

BMJ Open. 2018 Mar 22;8(3):e019003. doi: 10.1136/bmjopen-2017-019003.

8.

[Subclinical hypothyroidism : should we still treat elderly patients? Clinical implications of a new trial in primary care].

Collet TH, Sykiotis GP, Aubert CE, Baumgartner C, Blum MR, Feller M, Stettler C, Rodondi N.

Rev Med Suisse. 2018 Feb 28;14(596):470-474. French.

PMID:
29489127
9.

Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts.

Segna D, Bauer DC, Feller M, Schneider C, Fink HA, Aubert CE, Collet TH, da Costa BR, Fischer K, Peeters RP, Cappola AR, Blum MR, van Dorland HA, Robbins J, Naylor K, Eastell R, Uitterlinden AG, Rivadeneira Ramirez F, Gogakos A, Gussekloo J, Williams GR, Schwartz A, Cauley JA, Aujesky DA, Bischoff-Ferrari HA, Rodondi N; Thyroid Studies Collaboration.

J Intern Med. 2018 Jan;283(1):56-72. doi: 10.1111/joim.12688. Epub 2017 Oct 16.

10.

Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts.

Aubert CE, Floriani C, Bauer DC, da Costa BR, Segna D, Blum MR, Collet TH, Fink HA, Cappola AR, Syrogiannouli L, Peeters RP, Åsvold BO, den Elzen WPJ, Luben RN, Bremner AP, Gogakos A, Eastell R, Kearney PM, Hoff M, Le Blanc E, Ceresini G, Rivadeneira F, Uitterlinden AG, Khaw KT, Langhammer A, Stott DJ, Westendorp RGJ, Ferrucci L, Williams GR, Gussekloo J, Walsh JP, Aujesky D, Rodondi N; Thyroid Studies Collaboration.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2719-2728. doi: 10.1210/jc.2017-00294.

11.

Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.

Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, Sattar N, Aubert CE, Aujesky D, Bauer DC, Baumgartner C, Blum MR, Browne JP, Byrne S, Collet TH, Dekkers OM, den Elzen WPJ, Du Puy RS, Ellis G, Feller M, Floriani C, Hendry K, Hurley C, Jukema JW, Kean S, Kelly M, Krebs D, Langhorne P, McCarthy G, McCarthy V, McConnachie A, McDade M, Messow M, O'Flynn A, O'Riordan D, Poortvliet RKE, Quinn TJ, Russell A, Sinnott C, Smit JWA, Van Dorland HA, Walsh KA, Walsh EK, Watt T, Wilson R, Gussekloo J; TRUST Study Group.

N Engl J Med. 2017 Jun 29;376(26):2534-2544. doi: 10.1056/NEJMoa1603825. Epub 2017 Apr 3.

12.

Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis.

Chaker L, Baumgartner C, den Elzen WP, Collet TH, Ikram MA, Blum MR, Dehghan A, Drechsler C, Luben RN, Portegies ML, Iervasi G, Medici M, Stott DJ, Dullaart RP, Ford I, Bremner A, Newman AB, Wanner C, Sgarbi JA, Dörr M, Longstreth WT Jr, Psaty BM, Ferrucci L, Maciel RM, Westendorp RG, Jukema JW, Ceresini G, Imaizumi M, Hofman A, Bakker SJ, Franklyn JA, Khaw KT, Bauer DC, Walsh JP, Razvi S, Gussekloo J, Völzke H, Franco OH, Cappola AR, Rodondi N, Peeters RP; Thyroid Studies Collaboration.

J Clin Endocrinol Metab. 2016 Nov;101(11):4270-4282. Epub 2016 Sep 7.

13.

Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study.

Segna D, Méan M, Limacher A, Baumgartner C, Blum MR, Beer JH, Kucher N, Righini M, Matter CM, Frauchiger B, Cornuz J, Aschwanden M, Banyai M, Osterwalder J, Husmann M, Egloff M, Staub D, Lämmle B, Angelillo-Scherrer A, Aujesky D, Rodondi N.

J Thromb Haemost. 2016 Apr;14(4):685-94. doi: 10.1111/jth.13276. Epub 2016 Mar 23.

14.

Variation in treatment strategies of Swiss general practitioners for subclinical hypothyroidism in older adults.

Baumgartner C, den Elzen WP, Blum MR, Coslovsky M, Streit S, Frey P, Herzig L, Haller DM, Mooijaart SP, Bischoff T, Rosemann T, Gussekloo J, Rodondi N.

Swiss Med Wkly. 2015 Jul 28;145:w14156. doi: 10.4414/smw.2015.14156. eCollection 2015.

15.

Subclinical Thyroid Dysfunction and Depressive Symptoms among the Elderly: A Prospective Cohort Study.

Blum MR, Wijsman LW, Virgini VS, Bauer DC, den Elzen WP, Jukema JW, Buckley BM, de Craen AJ, Kearney PM, Stott DJ, Gussekloo J, Westendorp RG, Mooijaart SP, Rodondi N; PROSPER study group.

Neuroendocrinology. 2016;103(3-4):291-9. doi: 10.1159/000437387. Epub 2015 Jul 14.

16.

Subclinical thyroid dysfunction and fracture risk: a meta-analysis.

Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, Wirth CD, Peeters RP, Åsvold BO, den Elzen WP, Luben RN, Imaizumi M, Bremner AP, Gogakos A, Eastell R, Kearney PM, Strotmeyer ES, Wallace ER, Hoff M, Ceresini G, Rivadeneira F, Uitterlinden AG, Stott DJ, Westendorp RG, Khaw KT, Langhammer A, Ferrucci L, Gussekloo J, Williams GR, Walsh JP, Jüni P, Aujesky D, Rodondi N; Thyroid Studies Collaboration.

JAMA. 2015 May 26;313(20):2055-65. doi: 10.1001/jama.2015.5161.

17.

Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis.

Chaker L, Baumgartner C, den Elzen WP, Ikram MA, Blum MR, Collet TH, Bakker SJ, Dehghan A, Drechsler C, Luben RN, Hofman A, Portegies ML, Medici M, Iervasi G, Stott DJ, Ford I, Bremner A, Wanner C, Ferrucci L, Newman AB, Dullaart RP, Sgarbi JA, Ceresini G, Maciel RM, Westendorp RG, Jukema JW, Imaizumi M, Franklyn JA, Bauer DC, Walsh JP, Razvi S, Khaw KT, Cappola AR, Völzke H, Franco OH, Gussekloo J, Rodondi N, Peeters RP; Thyroid Studies Collaboration.

J Clin Endocrinol Metab. 2015 Jun;100(6):2181-91. doi: 10.1210/jc.2015-1438. Epub 2015 Apr 9. Review.

18.

Subclinical hypothyroidism: summary of evidence in 2014.

Baumgartner C, Blum MR, Rodondi N.

Swiss Med Wkly. 2014 Dec 23;144:w14058. doi: 10.4414/smw.2014.14058. eCollection 2014. Review.

19.

Patient and physician gender concordance in preventive care in university primary care settings.

Krähenmann-Müller S, Virgini VS, Blum MR, da Costa BR, Collet TH, Martin Y, Cornuz J, Zimmerli L, Gaspoz JM, Bauer DC, Kerr EA, Aujesky D, Rodondi N.

Prev Med. 2014 Oct;67:242-7. doi: 10.1016/j.ypmed.2014.08.004. Epub 2014 Aug 10.

20.

Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis.

Wirth CD, Blum MR, da Costa BR, Baumgartner C, Collet TH, Medici M, Peeters RP, Aujesky D, Bauer DC, Rodondi N.

Ann Intern Med. 2014 Aug 5;161(3):189-99. doi: 10.7326/M14-0125. Review.

21.

The lower quality of preventive care among forced migrants in a country with universal healthcare coverage.

Martin Y, Collet TH, Bodenmann P, Blum MR, Zimmerli L, Gaspoz JM, Battegay E, Cornuz J, Rodondi N.

Prev Med. 2014 Feb;59:19-24. doi: 10.1016/j.ypmed.2013.11.006. Epub 2013 Nov 18.

22.

[Dyslipidemia - when are lipid lowering medications useful in clinical practice?].

Blum MR, Stanga Z, Rodondi N.

Praxis (Bern 1994). 2013 May 8;102(10):585-9. doi: 10.1024/1661-8157/a001286. Review. German.

PMID:
23644243
23.

Long-term results of a 12-week comprehensive ambulatory cardiac rehabilitation program.

Blum MR, Schmid JP, Eser P, Saner H.

J Cardiopulm Rehabil Prev. 2013 Mar-Apr;33(2):84-90. doi: 10.1097/HCR.0b013e3182779b88.

PMID:
23385556
24.

Pharmacokinetics of emtricitabine/tenofovir disoproxil fumarate and tacrolimus at steady state when administered alone or in combination.

Chittick GE, Zong J, Begley JA, Alianti JR, Sorbel JJ, Blum MR.

Int J Clin Pharmacol Ther. 2008 Dec;46(12):627-36.

PMID:
19049696
25.

Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B.

Lim SG, Leung N, Hann HW, Lau GK, Trepo C, Mommeja-Marin H, Moxham C, Sorbel J, Snow A, Blum MR, Rousseau F, Marcellin P.

Aliment Pharmacol Ther. 2008 Jun;27(12):1282-92. doi: 10.1111/j.1365-2036.2008.03686.x. Epub 2008 Mar 22.

26.

Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects.

Saez-Llorens X, Violari A, Ndiweni D, Yogev R, Cashat M, Wiznia A, Chittick G, Harris J, Hinkle J, Blum MR, Adda N, Rousseau F; FTC-203 Study Team.

Pediatrics. 2008 Apr;121(4):e827-35. doi: 10.1542/peds.2006-3078. Epub 2008 Mar 10.

PMID:
18332076
27.

Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.

McKinney RE Jr, Rodman J, Hu C, Britto P, Hughes M, Smith ME, Serchuck LK, Kraimer J, Ortiz AA, Flynn P, Yogev R, Spector S, Draper L, Tran P, Scites M, Dickover R, Weinberg A, Cunningham C, Abrams E, Blum MR, Chittick GE, Reynolds L, Rathore M; Pediatric AIDS Clinical Trials Group Protocol P1021 Study Team.

Pediatrics. 2007 Aug;120(2):e416-23. Epub 2007 Jul 23.

PMID:
17646352
28.

Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers.

Zong J, Chittick GE, Wang LH, Hui J, Begley JA, Blum MR.

J Clin Pharmacol. 2007 Jul;47(7):877-89. Epub 2007 May 25.

PMID:
17526857
29.
30.

Pharmacokinetics of tenofovir disoproxil fumarate and ritonavir-boosted saquinavir mesylate administered alone or in combination at steady state.

Chittick GE, Zong J, Blum MR, Sorbel JJ, Begley JA, Adda N, Kearney BP.

Antimicrob Agents Chemother. 2006 Apr;50(4):1304-10.

31.

Intracellular pharmacology of emtricitabine and tenofovir.

Stevens RC, Blum MR, Rousseau FS, Kearney BP.

Clin Infect Dis. 2004 Sep 15;39(6):877-8; author reply 878-9. No abstract available.

PMID:
15472830
32.

A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B.

Marcellin P, Mommeja-Marin H, Sacks SL, Lau GK, Sereni D, Bronowicki JP, Conway B, Trepo C, Blum MR, Yoo BC, Mondou E, Sorbel J, Snow A, Rousseau F, Lee HS.

Hepatology. 2004 Jul;40(1):140-8.

PMID:
15239097
33.

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature.

Mommeja-Marin H, Mondou E, Blum MR, Rousseau F.

Hepatology. 2003 Jun;37(6):1309-19. Review.

PMID:
12774009
34.

Single-shot fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging of the bladder.

Daniel BL, Shimakawa A, Blum MR, Herfkens RJ.

J Magn Reson Imaging. 2000 Jun;11(6):673-7.

PMID:
10862067
35.

Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1.

Szczech GM, Furman P, Painter GR, Barry DW, Borroto-Esoda K, Grizzle TB, Blum MR, Sommadossi J, Endoh R, Niwa T, Yamamoto M, Moxham C.

Antimicrob Agents Chemother. 2000 Jan;44(1):123-30.

36.

Safety and pharmacokinetics of 5-chloro-2',3'-dideoxy-3'-fluorouridine (935U83) following oral administration of escalating single doses in human immunodeficiency virus-infected adults.

Riddler SA, Wang LH, Bartlett JA, Savina PM, Packard MV, McMahon DK, Blum MR, Dunn JA, Elkins MM, Mellors JW.

Antimicrob Agents Chemother. 1996 Dec;40(12):2842-7.

37.

Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.

Wang LH, Schultz M, Weller S, Smiley ML, Blum MR.

Antimicrob Agents Chemother. 1996 Jan;40(1):80-5.

38.

In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents.

St Clair MH, Millard J, Rooney J, Tisdale M, Parry N, Sadler BM, Blum MR, Painter G.

Antiviral Res. 1996 Jan;29(1):53-6.

PMID:
8721545
39.

Prolonged, but not diminished, zidovudine absorption induced by a high-fat breakfast.

Shelton MJ, Portmore A, Blum MR, Sadler BM, Reichman RC, Morse GD.

Pharmacotherapy. 1994 Nov-Dec;14(6):671-7.

PMID:
7885970
40.

Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.

Jacobson MA, Gallant J, Wang LH, Coakley D, Weller S, Gary D, Squires L, Smiley ML, Blum MR, Feinberg J.

Antimicrob Agents Chemother. 1994 Jul;38(7):1534-40.

41.

An unusual vascular hamartoma on the gingiva of an 11-year-old boy.

Blum MR, Williams B, Speight PM.

Int J Paediatr Dent. 1994 Mar;4(1):41-5.

PMID:
7748848
42.

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers.

Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P, Smiley ML.

Clin Pharmacol Ther. 1993 Dec;54(6):595-605.

PMID:
8275615
43.

Soft tissue chondroma of the cheek.

Blum MR, Danford M, Speight PM.

J Oral Pathol Med. 1993 Aug;22(7):334-6.

PMID:
8229872
45.

Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograft.

Laskowitz DT, Elion GB, Dewhirst MW, Griffith OW, Savina PM, Blum MR, Prescott DM, Bigner DD, Friedman HS.

Radiat Res. 1992 Feb;129(2):218-23.

PMID:
1734453
46.

Therapeutic analysis of melphalan-resistant human rhabdomyosarcoma xenograft TE-671 MR.

Lilley ER, Elion GB, Dewhirst MW, Schold SC Jr, Blum MR, Savina PM, Laskowitz DT, Bigner DD, Friedman HS.

Cancer Res. 1991 Aug 1;51(15):3906-9.

47.

A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U).

Weiss GR, Sarosy GA, Shenkenberg TD, Williams T, Clendeninn NJ, Von Hoff DD, Woolley JL, Liao SH, Blum MR.

Eur J Cancer Clin Oncol. 1989 Dec;25(12):1867-73.

PMID:
2632268
48.

Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex.

de Miranda P, Good SS, Yarchoan R, Thomas RV, Blum MR, Myers CE, Broder S.

Clin Pharmacol Ther. 1989 Nov;46(5):494-500.

PMID:
2582706
49.

Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus.

Drew RH, Weller S, Gallis HA, Walmer KA, Bartlett JA, Blum MR.

Antimicrob Agents Chemother. 1989 Oct;33(10):1801-3.

50.

Azidothymidine steady-state pharmacokinetics in patients with AIDS and AIDS-related complex.

Laskin OL, de Miranda P, Blum MR.

J Infect Dis. 1989 Apr;159(4):745-7. No abstract available.

PMID:
2926164

Supplemental Content

Support Center